Groundbreaking Study: 'Skinny Jab' Helps Half of Obese Children Achieve Healthy Weight

Semaglutide is a drug that is commonly used to treat type 2 diabetes by reducing hunger. Research carried out by Dr. Aaron Kelly, co-director of the Center for Pediatric Obesity Medicine at the University of Minnesota, found that almost 50% of children who received the "skinny jab" lost enough weight to no longer be classified as clinically obese.

Related Keywords

Tianjin ,China ,Beijing ,Dublin ,Ireland ,United Kingdom ,Aaron Kelly ,European Congress On Obesity ,University Of Minnesota ,Pediatric Obesity Medicine ,European Congress ,Getty Images ,Childhood Obesity ,Have Bias Against Fat Kids ,Semaglutide ,Obese Children ,Skinny Jab ,